Rigel Pharma (RIGL) Misses Q3 EPS by 1c

November 1, 2016 5:06 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Rigel Pharma (NASDAQ: RIGL) reported Q3 EPS of ($0.24), $0.01 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $3.8 million versus the consensus estimate of $3.97 million.

For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment